Cargando…
Recombinant-activated factor VII in patients with uncontrolled bleeding: A retrospective observational analysis
BACKGROUND: Factor VIIa (recombinant) has an off-label use to control life-threatening bleeding that is refractory to other measures and was shown to decrease transfusion requirements. OBJECTIVE: The primary objective of this study was to assess the safety and effectiveness of factor VIIa (recombina...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Medknow Publications & Media Pvt Ltd
2012
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3353622/ https://www.ncbi.nlm.nih.gov/pubmed/22623836 http://dx.doi.org/10.4103/0973-6247.95044 |